期刊文献+

肝损伤指数判断慢性肝炎转归的临床意义 被引量:3

Liver damage score for evaluation of the severity and prognosis of chronic liver diseases
原文传递
导出
摘要 目的 :建立一种生物数学指数判断肝损伤程度 ,评价慢性肝病患者预后 ,判定不同治疗方案的疗效。方法 :由肝脏蛋白合成能力、抗体产生水平、细胞裂解程度、胆汁郁积和肾功能损害等构成以生物数学和病理生理学为基础的肝损伤指数 (liverdamagescore ,LDS) ,对 4 86例慢性肝病患者的肝损伤程度、预后及疗效进行临床分析。结果 :LDS为 1.5~ 3U时 ,肝损伤为轻度 ;LDS为 3.7~ 5 .7U时 ,肝损伤为中等 ;LDS为 6~ 8U时 ,肝损伤较重 ;LDS >8U时 ,肝损伤最重 ,预后差 ;LDS能够反映疾病进展的过程和疗效。结论 :LDS是一种新的、简单而易操作的生物数学指数 ,能定量反映肝损伤程度和慢性肝病的发展过程 ,对指导临床治疗和判定预后具有重要意义。 Objective:To develop a biomathematical index for the estimation of the severity of liver damage, and to evaluate its capability for predicting prognosis of patients with chronic liver disease, for the estimation of the efficacy of different therapeutic regimens.Methods:Variables for reduced protein synthesis, increased production of antibodies, cytolysis, cholestasis, functional renal failure were combined into liver damage score (LDS) according to the results of cluster analysis. The evaluation of the liver injury and prognosis were analyzed in 486 patients with different liver diseases.Results:There were four groups of liver diseases: mild with LDS of 1.5-3?U, moderate with LDS of 3.7-5.7?U, severe with LDS of 6-8?U, the most severe with LDS >8?U. Values above 6 carried bad prognoisis. The LDS truthfully reflected the evolution of liver diseases over time and the efficacy of therapy.Conclusion:The LDS is a new, simple, low_cost, biomathematical and pathophysiological index for all patients with liver diseases. It allows a quantitative expression of the severity,the improvement or deterioration of the disease efficacy.
机构地区 解放军第
出处 《军事医学科学院院刊》 CSCD 北大核心 2003年第1期51-53,共3页 Bulletin of the Academy of Military Medical Sciences
关键词 肝损伤指数 肝炎 预后 liver damage score hepatitis prognosis
  • 相关文献

参考文献6

  • 1[1]Tygtrup N.Quantitative liver function test[A].In:Kweichen J,ed. Surrogate markers to assess efficacy of treatment in chronic liver diseases[M]. London:Kluuer Academic Publishers,1996.23-33.
  • 2[2]Christensen E,Schlichting P,Fauerholdt L,et al. Prognostic value of child-Turrcote criteria in medically treated cirrhosis[J]. Hepatology,1984,4(3):430-435.
  • 3[3]Orrego H,Israel Y,Blake JE,et al. Assessment of prognostic factors in alcholic liver diseases: toward a global quantitative expression of severity[J]. Hepatology,1983,3(1):896-905.
  • 4[4]Biermann J,Bode JC.Diagnose der alcohol-hepatitis[J].DMW,1987,9(2):347-349.
  • 5[5]Krastev Z. Liver damage score--a new index for evaluation of the severity of chronic liver diseases[J]. Hepato-Gastroenterology,1998,45(19):160-169.
  • 6[6]Hisao WA,Shinichi Y,Takashi M,et al. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection[J]. Hepato-Gastroenterology,2002,49(46):1048-1052.

同被引文献21

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2刘于宝,梁长虹,张忠林,余元新,谢淑飞,林韩斌,王秋实,郑君惠.^(31)P MR波谱成像在肝脏的初步临床应用研究[J].实用放射学杂志,2006,22(4):417-420. 被引量:11
  • 3Kawakita N, Seki S, Yanai A, et al. Immunocytochemical identification of proliferative hepatocytes using monoelonal antibody to proliferating cell nuclear antigen (PCNA/ cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha. Am J Clin Pathol, 1992,97 (5 Suppl 1) :S14-S20.
  • 4SchneeweissBi Graninger W, Ferenci P, et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology, 1990,11:387-393.
  • 5MorikawaS, Inubushi T, Kitoh K, et al. Chemical assessment of phospholipid and phosphoenergetic metabolites in regenerating rat liver measured by in vivo and in vitro ^31p- NMR. Biochim Biophys Acta, 1992,1117:251-257.
  • 6Schlemmer HP, Sawatzki T, Sammet S, et al. Hepatic phospholipids in alcoholic liver disease assessed by protondecoupled ^31p magnetic resonance spectroscopy. J Hepatol, 2005,42:752-759.
  • 7Corbin IR, Buist R, Volotovskyy V, et al. Regenerative activity and liver function following partial hepateetomy in the rat using (31) P-MR speetroscopy. Hepatology, 2002, 36,345-353.
  • 8Lira AK, Patel N, Hamilton G, et al. The relationship of in vivo ^31 p MR spectroscopy to histology in chronic hepatitis C. Hepatology, 2003, 37:788-794.
  • 9Munakata T, Griffiths RD, Martin PA, et al. An in vivo ^31p MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed, 1993,6 : 168-172.
  • 10Krastev Z. Liver damage score-a new index for evaluation of the severity of chronic liver diseases. Hepatogastroenterology, 1998, 45 : 160-169.

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部